Kaleidoscope
Making R&D more collaborative, reproducible, and scalable.

Latest

Oct
04

The 'too early to track' fallacy

When does it make sense to start tracking your work? In this Kaleidoscope blog, we explore a common misconception in
4 min read
Sep
18

The myth of biotech uniqueness

Every biotech is unique in some way, but biotechs have far more in common than most care to admit. In
4 min read
Aug
22

The psychology behind documentation burden in science

We all know scientists hate documenting things. What's behind this and how can we begin to address it,
5 min read
Aug
07

Why we invested in customer success at <10 people and <10 enterprise accounts

Customer success is a core pillar for most B2B businesses. But at product-driven startups, this typically isn't emphasized
4 min read
Jul
18

Stretching your capital: thinking long, thinking parallel

In high-stakes, capital-constrained environments, it's easy to put your head down and focus on putting one foot in
4 min read
Jun
21

Buying peace of mind

Most often, we buy software for functionality: a specific feature, a solution to an annoying problem. But with some categories
3 min read
May
29

Unlocking the Importance of Structure: Data vs Keys

Biotech R&D generates a vast and complex web of experimental data. To make informed decisions and drive analyses
4 min read
May
15

Culture is an overlooked competitive advantage: lessons from top biotech execs

Creating a culture of transparency and accountability is important – not just for driving company outcomes, but also for motivating team
4 min read
May
01

Plan smartly, execute precisely: the high-stakes game of chasing biotech value inflections

Successfully reaching the market in biotech hinges on building and maintaining a well-defined roadmap. One that clearly outlines the milestones
4 min read
Apr
10

Not your average data room

Data rooms are central in biotech: not only do they underpin key events like fundraising, asset licensing, and M&
6 min read